Now these are the kind of moves that needs to happen more often. Whether this will cause a negative impact on the overall market, and the further invention of drugs (including patent control), but the affordability of the medicatoin to an average citizen is a great move.
The typical Chemotherapy can be on an average of 22 times. When summed up with the dosage (somewhere around 250 mg IIRC), the cost comes to approx: (22/4) * 15000 = 82k, which now, will be affordable at 27k.
In the 3.x days of KDE, there were some wonderful applications. One of them I still admire, is kscope. Recently, I stumbled upon this blog entry and thought of sharing my living with kscope.
The move from KDE 3 to KDE 4 was a big one. During that move, the kscope author decided to port kscope to a Qt only application. That is what we have as the latest kscope, 1.9x version. But, on personal taste, it is not as good as the 1.6x series.